news
MRC Technology and IPS-CAS in antibody drug discovery collaboration
6 April 2016 | By Victoria White
The parties created IPS-MRCT Joint Centre for Therapeutic Antibodies in order to combine their expertise in research and development...
List view / Grid view
Antibody Discovery
news
Cellectis and MabQuest to develop new class of anti-PD-1 mAbs
17 March 2016 | By Victoria White
These anti-PD-1 mAbs have potential uses for multiple indications in immunotherapy, including notably treatments for a variety of cancers...
news
Single antibody protects non-human primates from Ebola virus
26 February 2016 | By Victoria White
A single monoclonal antibody isolated from a human survivor of Ebola virus completely protected monkeys from lethal infection with the virus...
news
Teva and AbCellera team up to discover monoclonal antibodies
3 February 2016 | By Victoria White
AbCellera will apply its high-throughput single cell antibody platform for the discovery of the rare monoclonal antibodies...
news
AbCellera and MSD enter antibody collaboration
28 January 2016 | By Victoria White
Under the agreement, AbCellera will apply its high-throughput antibody discovery platform to identify antibodies that specifically modulate target function...
news
Researchers isolate antibodies that neutralise multiple species of Ebola
22 January 2016 | By Victoria White
Researchers used a high-efficiency method they developed to quickly isolate and generate large quantities of monoclonal human antibodies from the blood of survivors of a 2007 outbreak in Uganda who were infected by the Bundibugyo Ebola virus...
news
F-star and AbbVie to develop bispecific antibodies in immuno-oncology
18 January 2016 | By Victoria White
Under the collaboration agreement, F-star and AbbVie will create Fcabs against two immuno-oncology targets and generate several mAb2 drug development candidates from these Fcabs...
news
An interview with Bernardo Perez-Ramirez, Sanofi, speaker at the 9th Annual Proteins & Antibodies Congress, 18-19 April 2016, London, UK
13 January 2016 | By Oxford Global
In anticipation of our Proteins and Antibodies Congress, Bernardo Perez-Ramirez spoke to us about his research and his expectations...
whitepaper
e-Book: Get the advantage with proven Ab discovery solutions
In this eBook you will learn how to shorten cell line development time and deliver stable clones with higher affinities and expression levels....
news
Ligand Pharmaceuticals to acquire OMT for $178 million
18 December 2015 | By Victoria White
OMT has leading antibody drug discovery technology and is believed to be the only company in the world offering three transgenic animal platforms for license...
news
BioAtla and Pfizer in CAB antibody collaboration
8 December 2015 | By Victoria White
BioAtla and Pfizer will each have a license to the other's respective technology to pursue the development and commercialisation of several CAB-ADC antibodies...
article
Protein Expression: The growing potential of plant-made monoclonal antibodies
The success story of Mapp Pharmaceuticals’ experimental drug, ZMapp, during last year’s Ebola outbreak highlights the potential of plant-made monoclonal antibodies (mAbs) as life-saving treatments.
news
XBiotech to develop antibody against C. Difficile
27 October 2015 | By Victoria White
Using its proprietary True Human technology, the Company has begun screening human blood samples from donors to identify and clone a therapeutic antibody candidate...
news
Scripps scientists make leukaemia cells kill each other
20 October 2015 | By Victoria White
The surprise finding could lead to a powerful new therapy for leukaemia and possibly other cancers...
news
Lilly and Innovent expand anti-PD-1 bispecific antibody collaboration
12 October 2015 | By Victoria White
As part of the expanded collaboration, Innovent could receive additional milestones totalling more than $1 billion if the products reach certain milestones...
